Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study
Keyword(s):
Keyword(s):
2019 ◽
Vol 28
(2)
◽
pp. 151-157
◽
2019 ◽
Vol 49
(1)
◽
pp. 27-38
Keyword(s):
2018 ◽
Vol 23
◽
pp. 171-175
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 38
(4)
◽
pp. 1296-1302
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 15
(7)
◽
pp. 738-742
◽
Keyword(s):
Keyword(s):
Keyword(s):